|
1
|
Chen HZ, Zhong NS, Lu ZY, et al: The
eighth rdition Textbook of Surgery[M]// published by People's
Education Press: Saunders, 2013:708-709. Primary aldosteronism is
characterized by the overproduction of the mineralocorticoid
hormone aldosterone by the adrenal glands, adrenal cortex
hyperplasia or adrenal carcinoma main cause the disease; Symptoms:
Occasional muscular weakness, muscle spasms, tingling sensations,
or excessive urination the prevalence of APA in hypertension is 10
percent, and the symptom and incidence is like PA.
|
|
2
|
Rossi GP, Bolognesi M, Rizzoni D, Seccia
TM, Piva A, Porteri E, Tiberio GA, Giulini SM, Agabiti-Rosei E and
Pessina AC: Vascular remodeling and duration of hypertension
predict outcome of adrenalectomy in primary aldosteronism patients.
Hypertension. 51:1366–1371. 2008.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Yan Y, Ouyang J, Wang C, Wu Z, Ma X, Li H,
Xu H, Hu Z, Li J, Wang B, et al: Aortic cell apoptosis in rat
primary aldosteronism model. J Huazhong Univ Sci Technolog Med Sci.
30:385–390. 2010.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Xiao W, Zhou S, Xu H, Li H, He G, Liu Y
and Qi Y: Nogo-B promotes the epithelial-mesenchymal transition in
HeLa cervical cancer cells via Fibulin-5. Oncol Rep. 29:109–116.
2013.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Kapustin A, Stepanova V, Aniol N, Cines
DB, Poliakov A, Yarovoi S, Lebedeva T, Wait R, Ryzhakov G,
Parfyonova Y, et al: Fibulin-5 binds urokinase-type plasminogen
activator and mediates urokinase-stimulated β1-integrin-dependent
cell migration. Biochem J. 443:491–503. 2012.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Spencer JA, Hacker SL, Davis EC, Mecham
RP, Knutsen RH, Li DY, Gerard RD, Richardson JA, Olson EN and
Yanagisawa H: Altered vascular remodeling in fibulin-5-deficient
mice reveals a role of fibulin-5 in smooth muscle cell
proliferation and migration. Proc Natl Acad Sci USA. 102:2946–2951.
2005.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Ding W, Yang L, Zhang M and Gu Y: Reactive
oxygen species-mediated endoplasmic reticulum stress contributes to
aldosterone-induced apoptosis in tubular epithelial cells. Biochem
Biophys Res Commun. 418:451–456. 2012.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Schiemann WP, Blobe GC, Kalume DE, Pandey
A and Lodish HF: Context-specific effects of fibulin-5 (DANCE/EVEC)
on cell proliferation, motility, and invasion. Fibulin-5 is induced
by transforming growth factor-beta and affects protein kinase
cascades. J Biol Chem. 277:27367–27377. 2002.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Schluterman MK, Chapman SL, Korpanty G,
Ozumi K, Fukai T, Yanagisawa H and Brekken RA: Loss of fibulin-5
binding to beta1 integrins inhibits tumor growth by increasing the
level of ROS. Dis Model Mech. 3:333–342. 2010.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Sullivan KM, Bissonnette R, Yanagisawa H,
Hussain SN and Davis EC: Fibulin-5 functions as an endogenous
angiogenesis inhibitor. Lab Invest. 87:818–827. 2007.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Albig AR, Neil JR and Schiemann WP:
Fibulins 3 and 5 antagonize tumor angiogenesis in vivo. Cancer Res.
66:2621–2629. 2006.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Guadall A, Orriols M, Rodríguez-Calvo R,
Calvayrac O, Crespo J, Aledo R, Martínez-González J and Rodríguez
C: Fibulin-5 is up-regulated by hypoxia in endothelial cells
through a hypoxia-inducible factor-1 (HIF-1α)-dependent mechanism.
J Biol Chem. 286:7093–7103. 2011.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408.
2001.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Qiao W, Zhang W, Shao S, Gai Y and Zhang
M: Effect and mechanism of poly (ADP-ribose) polymerase-1 in
aldosterone-induced apoptosis. Mol Med Rep. 12:1631–1638.
2015.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Ishizawa K, Izawa Y, Ito H, Miki C, Miyata
K, Fujita Y, Kanematsu Y, Tsuchiya K, Tamaki T, Nishiyama A and
Yoshizumi M: Aldosterone stimulates vascular smooth muscle cell
proliferation via big mitogen-activated protein kinase 1
activation. Hypertension. 46:1046–1052. 2005.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Young WF Jr: Minireview: Primary
aldosteronism-changing concepts in diagnosis and treatment.
Endocrinology. 144:2208–2213. 2003.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Hayashi H, Kobara M, Abe M, Tanaka N,
Gouda E, Toba H, Yamada H, Tatsumi T, Nakata T and Matsubara H:
Aldosterone nongenomically produces NADPH oxidase-dependent
reactive oxygen species and induces myocyte apoptosis. Hypertens
Res. 31:363–375. 2008.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Korshunov VA and Berk BC: Smooth muscle
apoptosis and vascular remodeling. Curr Opin Hematol. 15:250–254.
2008.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Calvier L, Miana M, Reboul P, Cachofeiro
V, Martinez-Martinez E, de Boer RA, Poirier F, Lacolley P, Zannad
F, Rossignol P and López-Andrés N: Galectin-3 mediates
aldosterone-induced vascular fibrosis. Arterioscler Thromb Vasc
Biol. 33:67–75. 2013.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Takeda Y, Miyamori I, Yoneda T, Iki K,
Hatakeyama H, Blair IA, Hsieh FY and Takeda R: Production of
aldosterone in isolated rat blood vessels. Hypertension.
25:170–173. 1995.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Leopold JA: Aldosterone, mineralocorticoid
receptor activation, and cardiovascular remodeling. Circulation.
124:e466–e468. 2011.PubMed/NCBI View Article : Google Scholar
|
